0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Musculoskeletal medicine

Buy Now

Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta (Paperback) Loot Price: R934
Discovery Miles 9 340
Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta (Paperback): Meena Balasubramanian

Clinical and Molecular Heterogeneity of Osteogenesis Imperfecta (Paperback)

Meena Balasubramanian; Series edited by Dhavendra Kumar

Series: Colloquium Series on Genomic and Molecular Medicine

 (sign in to rate)
Loot Price R934 Discovery Miles 9 340 | Repayment Terms: R88 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Osteogenesis imperfecta (OI) is a disease encompassing a group of disorders mainly characterized by bone fragility and is the commonest form of heritable bone fragility. In this book, the clinical presentations with particular emphasis on rare phenotypes associated with OI are discussed together with molecular advances in diagnosis and treatment of OI. There is a broad spectrum of clinical severity in OI, ranging from multiple fractures in utero and perinatal death, to near-normal adult stature and low fracture incidence. Facial dysmorphism has been noted, but is not well described, nor is it an invariable feature. Sillence et al., in 1979, provided the clinical classification, which has been further expanded. Genetic defects in type 1 collagen can be identified in 85% of patients with a clinical diagnosis of OI, that is, mutations in COL1A1/COL1A2, which follows an autosomal dominant pattern of inheritance. Several genes have now been implicated in autosomal recessive forms of OI and X-linked osteoporosis. Given the possible antenatal presentation and prognosis associated with OI, it is important to make this diagnosis early and be able to distinguish this from other lethal skeletal dysplasias. It is also important to distinguish nonaccidental injury from a pathological cause of fractures, such as OI, and diagnose this promptly in these situations. However, this is not always possible due to variability in presentation and inability to pinpoint the precise genetic etiology despite extensive genetic testing. OI is one such rare genetic condition where treatment is available in the form of bisphosphonates, which has a huge impact on quality of life. Despite advances in medical therapy, multidisciplinary management including physiotherapy remains the mainstay of treatment and improved outcomes in OI.

General

Imprint: Morgan & Claypool Publishers
Country of origin: United States
Series: Colloquium Series on Genomic and Molecular Medicine
Release date: 2017
Authors: Meena Balasubramanian
Series editors: Dhavendra Kumar
Dimensions: 235 x 191 x 4mm (L x W x T)
Format: Paperback
Pages: 63
ISBN-13: 978-1-61504-744-4
Categories: Books > Medicine > Clinical & internal medicine > Musculoskeletal medicine
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General
LSN: 1-61504-744-1
Barcode: 9781615047444

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners